drugset / Trial / NCT01601509

Nasal Tramazoline and Dexamethazone in Obstructive Sleep Apnea (OSA) Patients Tramazoline and

NCT01601509 ↗

Completed 23 enrolled University of Athens
RandomizedCrossoverQuadruple-blindTreatment

Summary

Nasal resistance presents considerable variations during night\[8\]. Additionally, Oral and oro-nasal breathing epochs exhibit strong correlation with the number of apnoea/hypopnoeas \[7\].The hypothesis that the present study aims to test is whether the pharmacological prevention of increased nasal resistance during night could alter breathing route pattern and lead to a decrease in the number of apnoea/hypopnoeas in OSA patients with normal nasal resistance.

Timeline

Start
2010-04
Primary completion
2012-05
Completion
2012-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexamethasone Small molecule — Intranasal
Comparator tramazoline Small molecule — Intranasal